Paediatric Nephrology Competence based Training
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2015 - Ongoing
Project Lead
Dr. Arpana Iyenger, Dr. Tony Raj
Authors
Dr. Arpana Iyenger, Dr. Tony Raj
Project Status
completed
Project Type
Navajbai Ratan Tata Trust